840 related articles for article (PubMed ID: 29357437)
1. Renal ischemia-reperfusion injury causes hypertension and renal perfusion impairment in the CD1 mice which promotes progressive renal fibrosis.
Greite R; Thorenz A; Chen R; Jang MS; Rong S; Brownstein MJ; Tewes S; Wang L; Baniassad B; Kirsch T; Bräsen JH; Lichtinghagen R; Meier M; Haller H; Hueper K; Gueler F
Am J Physiol Renal Physiol; 2018 May; 314(5):F881-F892. PubMed ID: 29357437
[TBL] [Abstract][Full Text] [Related]
2. Early antihypertensive treatment and ischemia-induced acute kidney injury.
Greite R; Derlin K; Hensen B; Thorenz A; Rong S; Chen R; Hellms S; Jang MS; Bräsen JH; Meier M; Willenberg I; Immenschuh S; Haller H; Luft FC; Panigrahy D; Hwang SH; Hammock BD; Schebb NH; Gueler F
Am J Physiol Renal Physiol; 2020 Oct; 319(4):F563-F570. PubMed ID: 32799675
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency contributes to vascular damage in sustained ischemic acute kidney injury.
de Bragança AC; Volpini RA; Mehrotra P; Andrade L; Basile DP
Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27369932
[TBL] [Abstract][Full Text] [Related]
4. Functional MRI for characterization of renal perfusion impairment and edema formation due to acute kidney injury in different mouse strains.
Tewes S; Gueler F; Chen R; Gutberlet M; Jang MS; Meier M; Mengel M; Hartung D; Wacker F; Rong S; Hueper K
PLoS One; 2017; 12(3):e0173248. PubMed ID: 28319118
[TBL] [Abstract][Full Text] [Related]
5. Unilateral Renal Ischemia-Reperfusion as a Robust Model for Acute to Chronic Kidney Injury in Mice.
Le Clef N; Verhulst A; D'Haese PC; Vervaet BA
PLoS One; 2016; 11(3):e0152153. PubMed ID: 27007127
[TBL] [Abstract][Full Text] [Related]
6. Caspase-3-dependent peritubular capillary dysfunction is pivotal for the transition from acute to chronic kidney disease after acute ischemia-reperfusion injury.
Lan S; Yang B; Migneault F; Turgeon J; Bourgault M; Dieudé M; Cardinal H; Hickey MJ; Patey N; Hébert MJ
Am J Physiol Renal Physiol; 2021 Sep; 321(3):F335-F351. PubMed ID: 34338031
[TBL] [Abstract][Full Text] [Related]
7. New mouse model of chronic kidney disease transitioned from ischemic acute kidney injury.
Wei J; Zhang J; Wang L; Jiang S; Fu L; Buggs J; Liu R
Am J Physiol Renal Physiol; 2019 Aug; 317(2):F286-F295. PubMed ID: 31116604
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of unilateral ischemia-reperfusion injury: importance of renal counterbalance and implications for the AKI-CKD transition.
Polichnowski AJ; Griffin KA; Licea-Vargas H; Lan R; Picken MM; Long J; Williamson GA; Rosenberger C; Mathia S; Venkatachalam MA; Bidani AK
Am J Physiol Renal Physiol; 2020 May; 318(5):F1086-F1099. PubMed ID: 32174143
[TBL] [Abstract][Full Text] [Related]
9. Blockade of cysteine-rich protein 61 attenuates renal inflammation and fibrosis after ischemic kidney injury.
Lai CF; Lin SL; Chiang WC; Chen YM; Wu VC; Young GH; Ko WJ; Kuo ML; Tsai TJ; Wu KD
Am J Physiol Renal Physiol; 2014 Sep; 307(5):F581-92. PubMed ID: 24920753
[TBL] [Abstract][Full Text] [Related]
10. A two-stage bilateral ischemia-reperfusion injury-induced AKI to CKD transition model in mice.
Zhang J; Wang X; Wei J; Wang L; Jiang S; Xu L; Qu L; Yang K; Fu L; Buggs J; Cheng F; Liu R
Am J Physiol Renal Physiol; 2020 Aug; 319(2):F304-F311. PubMed ID: 32567350
[TBL] [Abstract][Full Text] [Related]
11. Peritubular capillary preservation with COMP-angiopoietin-1 decreases ischemia-reperfusion-induced acute kidney injury.
Jung YJ; Kim DH; Lee AS; Lee S; Kang KP; Lee SY; Jang KY; Sung MJ; Park SK; Kim W
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F952-60. PubMed ID: 19656917
[TBL] [Abstract][Full Text] [Related]
12. Caspase-3 Is a Pivotal Regulator of Microvascular Rarefaction and Renal Fibrosis after Ischemia-Reperfusion Injury.
Yang B; Lan S; Dieudé M; Sabo-Vatasescu JP; Karakeussian-Rimbaud A; Turgeon J; Qi S; Gunaratnam L; Patey N; Hébert MJ
J Am Soc Nephrol; 2018 Jul; 29(7):1900-1916. PubMed ID: 29925521
[No Abstract] [Full Text] [Related]
13. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.
Menshikh A; Scarfe L; Delgado R; Finney C; Zhu Y; Yang H; de Caestecker MP
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1383-F1397. PubMed ID: 31509009
[TBL] [Abstract][Full Text] [Related]
14. The Atypical Chemokine Receptor 2 Limits Progressive Fibrosis after Acute Ischemic Kidney Injury.
Lux M; Blaut A; Eltrich N; Bideak A; Müller MB; Hoppe JM; Gröne HJ; Locati M; Vielhauer V
Am J Pathol; 2019 Feb; 189(2):231-247. PubMed ID: 30448408
[TBL] [Abstract][Full Text] [Related]
15. The role of podocyte damage in the etiology of ischemia-reperfusion acute kidney injury and post-injury fibrosis.
Chen Y; Lin L; Tao X; Song Y; Cui J; Wan J
BMC Nephrol; 2019 Mar; 20(1):106. PubMed ID: 30922260
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence microangiography for quantitative assessment of peritubular capillary changes after AKI in mice.
Kramann R; Tanaka M; Humphreys BD
J Am Soc Nephrol; 2014 Sep; 25(9):1924-31. PubMed ID: 24652794
[TBL] [Abstract][Full Text] [Related]
17. Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis.
Picken M; Long J; Williamson GA; Polichnowski AJ
Hypertension; 2016 Oct; 68(4):921-8. PubMed ID: 27550923
[TBL] [Abstract][Full Text] [Related]
18. Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury.
Guo J; Guan Q; Liu X; Wang H; Gleave ME; Nguan CY; Du C
BMC Nephrol; 2016 Sep; 17(1):133. PubMed ID: 27649757
[TBL] [Abstract][Full Text] [Related]
19. Diabetes Aggravates Post-ischaemic Renal Fibrosis through Persistent Activation of TGF-β
Kim DJ; Kang JM; Park SH; Kwon HK; Song SJ; Moon H; Kim SM; Seo JW; Lee YH; Kim YG; Moon JY; Lee SY; Son Y; Lee SH
Sci Rep; 2017 Dec; 7(1):16782. PubMed ID: 29196746
[TBL] [Abstract][Full Text] [Related]
20. IL-17A blockade or deficiency does not affect progressive renal fibrosis following renal ischaemia reperfusion injury in mice.
Thorenz A; Völker N; Bräsen JH; Chen R; Jang MS; Rong S; Haller H; Kirsch T; Vieten G; Klemann C; Gueler F
J Pharm Pharmacol; 2017 Sep; 69(9):1125-1135. PubMed ID: 28573734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
